263 results on '"Johanson, Per"'
Search Results
2. Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor
3. Abstract 12923: Development of a Novel Biomarker-based Risk Score for Heart Failure in Patients With Diabetes
4. Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF
5. Exchange of Modular Components Improves Success of Debridement, Antibiotics, and Implant Retention: An Observational Study of 575 Patients with Infection After Primary Total Hip Arthroplasty
6. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58
7. Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus
8. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
9. Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54
10. Early Subsidence Predicts Failure of a Cemented Femoral Stem With Minor Design Changes
11. Wear of Vitamin E-Infused Highly Cross-Linked Polyethylene at Five Years
12. Prehospital ECG signs of acute coronary occlusion are associated with reduced one-year mortality
13. Small Changes in Troponin T Levels Are Common in Patients With Non–ST-Segment Elevation Myocardial Infarction and Are Linked to Higher Mortality
14. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes
15. Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial
16. Influence of ST-Segment Recovery on Infarct Size and Ejection Fraction in Patients With ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention
17. Femoral Head Penetration of Vitamin E-Infused Highly Cross-Linked Polyethylene Liners: A Randomized Radiostereometric Study of Seventy Hips Followed for Two Years
18. ST Resolution 1 Hour After Fibrinolysis for Prediction of Myocardial Infarct Size: Insights from ASSENT 3
19. Highly Crosslinked Polyethylene Does Not Reduce Aseptic Loosening in Cemented THA 10-year Findings of a Randomized Study
20. Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
21. An Academic ECG Core Lab Perspective of the FDA Initiative for Digital ECG Capture and Data Management in Large-Scale Clinical Trials
22. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines
23. ST-segment monitoring in patients with acute coronary syndromes
24. ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy
25. 'Mirror-lake' serial relationship of Electrocardiographic and biochemical indices for the detection of reperfusion and the predidtion of salvage in patients with acute myocardial infarction
26. Characteristics of and outcome for patients with chest pain in relation to transport by the emergency medical services in a 20-year perspective
27. Inequalities in the early treatment of women and men with acute chest pain?
28. Third universal definition of myocardial infarction
29. Continuous ST monitoring: a bedside instrument?
30. Evidence-Based Treatment and ST-Segment Elevation Myocardial Infarction—Reply
31. Association Between Adoption of Evidence-Based Treatment and Survival for Patients With ST-Elevation Myocardial Infarction
32. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial
33. Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial
34. Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
35. Wear measurements with use of radiostereometric analysis in total hip arthroplasty with obscured femoral head
36. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54
37. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.
38. A dynamic model forecasting myocardial infarct size before, during, and after reperfusion therapy: an ASSENT-2 ECG/VCG substudy
39. Assessment of derived 12-lead electrocardiograms using general and patient-specific reconstruction strategies at rest and during transient myocardial ischemia
40. Aborted infarction: The ultimate myocardial salvage
41. Admission Troponin T and measurement of ST-segment resolution at 60 min improve early risk stratification in ST-elevation myocardial infarction
42. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54
43. Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54
44. Improvements in hip arthroplasty - did they work? Evaluations of different articulations and fixation concepts
45. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54
46. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.
47. Decreased admissions and hospital costs with a neutral effect on mortality following lowering of the troponin T cutoff point to the 99th percentile
48. Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54
49. Phylogeny of Lungfi shes
50. Outcome in design-specific comparisons between highly crosslinked and conventional polyethylene in total hip arthroplasty
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.